These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7857874)

  • 1. Molecular modelling of the human estrogen receptor and ligand interactions based on site-directed mutagenesis and amino acid sequence homology.
    Lewis DF; Parker MG; King RJ
    J Steroid Biochem Mol Biol; 1995 Jan; 52(1):55-65. PubMed ID: 7857874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
    Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FLP recombinase/estrogen receptor fusion proteins require the receptor D domain for responsiveness to antagonists, but not agonists.
    Nichols M; Rientjes JM; Logie C; Stewart AF
    Mol Endocrinol; 1997 Jun; 11(7):950-61. PubMed ID: 9178754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of free DNA on the interactions of the estrogen receptor bound to hormone, partial antagonist or pure antagonist with target DNA.
    Aliau S; Groblewski T; Borgna JL
    Eur J Biochem; 1995 Jul; 231(1):204-13. PubMed ID: 7628472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains.
    Métivier R; Penot G; Flouriot G; Pakdel F
    Mol Endocrinol; 2001 Nov; 15(11):1953-70. PubMed ID: 11682626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of Leu-536 in human estrogen receptor-alpha alters the coupling between ligand binding, transcription activation, and receptor conformation.
    Zhao C; Koide A; Abrams J; Deighton-Collins S; Martinez A; Schwartz JA; Koide S; Skafar DF
    J Biol Chem; 2003 Jul; 278(29):27278-86. PubMed ID: 12736255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different residues of the human estrogen receptor are involved in the recognition of structurally diverse estrogens and antiestrogens.
    Ekena K; Weis KE; Katzenellenbogen JA; Katzenellenbogen BS
    J Biol Chem; 1997 Feb; 272(8):5069-75. PubMed ID: 9030571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of "pure" antiestrogens in inhibiting estrogen receptor action.
    Parker MG
    Breast Cancer Res Treat; 1993; 26(2):131-7. PubMed ID: 8219250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists.
    Mahfoudi A; Roulet E; Dauvois S; Parker MG; Wahli W
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4206-10. PubMed ID: 7753783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization.
    Chen D; Pace PE; Coombes RC; Ali S
    Mol Cell Biol; 1999 Feb; 19(2):1002-15. PubMed ID: 9891036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of bacterially expressed rat estrogen receptor beta ligand binding domain by mass spectrometry: structural comparison with estrogen receptor alpha.
    Witkowska HE; Carlquist M; Engström O; Carlsson B; Bonn T; Gustafsson JA; Shackleton CH
    Steroids; 1997; 62(8-9):621-31. PubMed ID: 9292936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
    MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
    Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
    Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
    Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate.
    Borgna JL; Scali J
    J Steroid Biochem; 1988 Oct; 31(4A):427-36. PubMed ID: 3050278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxyl or counterpart hydroxyl with histidine 524 of the human estrogen receptor alpha.
    Aliau S; Mattras H; Richard E; Bonnafous JC; Borgna JL
    Biochemistry; 2002 Jun; 41(25):7979-88. PubMed ID: 12069588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site.
    Anstead GM; Carlson KE; Katzenellenbogen JA
    Steroids; 1997 Mar; 62(3):268-303. PubMed ID: 9071738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity.
    Greschik H; Flaig R; Renaud JP; Moras D
    J Biol Chem; 2004 Aug; 279(32):33639-46. PubMed ID: 15161930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone binding and transcription activation by estrogen receptors: analyses using mammalian and yeast systems.
    Katzenellenbogen BS; Bhardwaj B; Fang H; Ince BA; Pakdel F; Reese JC; Schodin D; Wrenn CK
    J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):39-48. PubMed ID: 8274440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of a tamoxifen-raloxifene hybrid ligand for estrogen receptors at an AP-1 site.
    Weatherman RV; Carroll DC; Scanlan TS
    Bioorg Med Chem Lett; 2001 Dec; 11(24):3129-31. PubMed ID: 11720858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. William L. McGuire Memorial Symposium. Estrogen receptors: ligand discrimination and antiestrogen action.
    Katzenellenbogen BS; Fang H; Ince BA; Pakdel F; Reese JC; Wooge CH; Wrenn CK
    Breast Cancer Res Treat; 1993; 27(1-2):17-26. PubMed ID: 8260727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.